Christopher McGorry

Associate Director, R&D Financial and Stategic Planning at Dicerna Pharmaceuticals - Lexington, MA, US

Christopher McGorry's Contact Details
HQ
617-621-8097
Location
Company
Dicerna Pharmaceuticals
Christopher McGorry's Company Details
Dicerna Pharmaceuticals logo, Dicerna Pharmaceuticals contact details

Dicerna Pharmaceuticals

Lexington, MA, US • 500 - 999 Employees
Major Drugs

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXC™ and GalXC-Plus™ RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with GalXC-Plus, which expands on the functionality and application of our flagship liver-targeted GalXC technology to tissues and cell types outside the liver with the potential to treat diseases across multiple therapeutic areas. Our team brings together talented experts across the fields of biology, chemistry, clinical science, medicine and more. With decades of scientific and technical experience focused on RNAi technology, we have the knowledge and experience needed to discover and develop therapies for patients with serious unmet medical needs. Between our own pipeline of core discovery and clinical candidates and those developed through collaborative relationships with some of the world's leading pharmaceutical companies, we have generated more than 20 active discovery, preclinical or clinical proprietary and collaborative programs focused on rare, cardiometabolic, viral, chronic liver and complement-mediated diseases, as well as neurodegenerative diseases and pain.

B2B Biotechnology Healthcare Pharmaceuticals Major Drugs Pharmaceutical Preparations Biotech Pharmaceuticals
Details about Dicerna Pharmaceuticals
Frequently Asked Questions about Christopher McGorry
Christopher McGorry currently works for Dicerna Pharmaceuticals, Inc.
Christopher McGorry's role at Dicerna Pharmaceuticals, Inc is Associate Director, R&D Financial and Stategic Planning.
Christopher McGorry's email address is ***@dicerna.com. To view Christopher McGorry's full email address, please signup to ConnectPlex.
Christopher McGorry works in the Pharmaceuticals industry.
Christopher McGorry's colleagues at Dicerna Pharmaceuticals are Vicky Lyon, Anthony Davis, John PharmD, Samantha Wilkes, Christianna Locaciato, Rupesh Rai, Ling Zeng and others.
Christopher McGorry's phone number is 617-621-8097
See more information about Christopher McGorry